« Previous
Next »
Archives of Physical Medicine and Rehabilitation
Volume 90, Issue 4
, Pages
545-552
, April 2009
Preventing Progression to Chronicity in First Onset, Subacute Low Back Pain: An Exploratory Study
-
Progress of participants through the trial. Participants identified as completing the trial attended all 4 sessions of behavioral medicine or attention control therapy and were assessed at follow-up 6
Progress of participants through the trial. Participants identified as completing the trial attended all 4 sessions of behavioral medicine or attention control therapy and were assessed at follow-up 6 months after pain onset.
Supported by the Office of Research and Development, Health Services Research and Development Service and Medical Research Service, Department of Veterans Affairs (grant no. IIR-94-028).
The opinions expressed are those of the authors and do not reflect the official policy or position of the Department of the Navy, the Department of Defense, or the United States Government. The voluntary informed consent of the subjects used in this research was obtained as required by SECNAVINST 3900.39B. The Chief, Bureau of Medicine and Surgery, Navy Department, Washington, DC, Clinical Investigation Program, sponsored this report, as required by HSETCINST 6000.41A.
A commercial party having a direct financial interest in the results of the research supporting this article has conferred or will confer a financial benefit on 1 of the authors. Dr Atkinson is on the Scientific Advisory Board of Eli Lilly, which sells antidepressants, an alternative treatment method for low back pain.
Reprints are not available from the author.
PII: S0003-9993(09)00082-3
doi: 10.1016/j.apmr.2008.10.032
« Previous
Next »
Archives of Physical Medicine and Rehabilitation
Volume 90, Issue 4
, Pages
545-552
, April 2009
